Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
A double-blind randomized phase II treatment trial (Parallel Assignment) comparing Fecal Microbiota Transplantation (FMT) from healthy donors with autologous Fecal Microbiota Transplantation (FMT) (placebo) in 50 patients with mild to moderately active Ulcerative Colitis (UC) (1)
Clinical remission, as well as reduction of Mayo endoscopic inflammation score
Thirty-seven patients completed the primary endpoint assessment. In the intention-to-treat analysis, 30.4% of patients receiving fecal transplants (FMT) from healthy donors and 20.0% of controls achieved the primary endpoint (P = .51). In the per-protocol analysis, 41.2% …